CV-04
Target
Indication
Hit
Lead
Tox
Non-Clinical
Ph 1
Detail
PPARδ
Neurodegenerative diseases
Neurological diseases
Chronic inflammation
Target
Indication
Lead
PPARδ
Neurodegenerative diseases
Neurological diseases
Chronic inflammation
A therapeutic that activates PPARδ
Inhibiting inflammation, improving sarcopenia, and enhancing cognitive function
We aim to develop a safer drug with fewer side effects by leveraging its superior selectivity compared to commercialized and clinical-stage drugs.
